Monday, September 29, 2014

Seattle Genetics, Takeda's cancer drug meets main goal in trial

The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg (Reuters) - Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Consolidation therapy is given to cancer patients who have undergone initial therapy and kills any cancer cells that may be left in the body. ...








via Health News Headlines - Yahoo News http://ift.tt/10diX6J

Tonix Pharma's pain drug fails mid-stage study

(Reuters) - Tonix Pharmaceuticals Holding Corp said its lead pain drug had failed the main goal of a mid-stage study testing if it reduced pain experienced by patients by the 12th week of the trial. The drug, TNX-102, is being tested to treat fibromyalgia, a chronic syndrome characterized by widespread pain and lack of sleep. The treatment, however, improved sleep quality in patients, one of the key secondary goals of the trial, Tonix said. The company said it planned to discuss the trial results and the design for a late-stage trial of the drug with the U.S. Food and Drug Administration. ...



via Health News Headlines - Yahoo News http://ift.tt/1rxrOKW

Puma Biotechnology cancer drug shows positive mid-stage results

(Reuters) - Puma Biotechnology Inc said its experimental lung cancer drug was safe to be administered with an already approved treatment for the disease in a mid-stage study. The time where a patient's disease did not progress increased to four months when given a combination of Puma's PB272 and temsirolimus, compared to about three months when given only PB272, according to data from the study. All the patients in the study were given a high dose of the drug loperamide to prevent diarrhea related to PB272. There were no severe diarrhea events seen in the trial, the company said. ...



via Health News Headlines - Yahoo News http://ift.tt/1vor9fS

Full plates fight prejudice in Hungary restaurant

Guests sit in Izlelo, a restaurant in Szekszard By Gergely Szakacs SZEKSZARD Hungary (Reuters) - Waitress Maria Kecskemeti says working with people is a daily challenge, requiring much skill and empathy. She also admits to initially being somewhat scared of how guests would react when she took the first orders from her wheelchair. Kecskemeti works at Izlelo, a restaurant set up in 2007 by a local foundation to help handicapped people find employment. She is one of 15 employees, most of whom have some type of disability like deafness or a learning disability. ...








via Health News Headlines - Yahoo News http://ift.tt/1ny6xkx

Hundreds of firms join global hunt for copycat biotech drugs

By Ben Hirschler (Reuters) - Hundreds of companies around the world are chasing an emerging market for cheaper copies of costly biotech drugs, with more than 700 so-called biosimilars now in development or already approved, according to a major study of the sector. Biotech medicines - made from proteins and other large molecules - account for six of the 10 biggest-selling drugs in the world today, led by AbbVie's $12 billion-a-year rheumatoid arthritis injection Humira. ...



via Health News Headlines - Yahoo News http://ift.tt/1volRRA

India's Jaitley in isolation ward, may skip U.S. trip

By Manoj Kumar NEW DELHI (Reuters) - India's Finance Minister Arun Jaitley may have to cancel a trip to the United States in October after he was moved to an isolation ward of a government-run hospital to help him recover from an infection that followed a stomach operation to treat diabetes. Jaitley is due to attend a World Bank meeting on Oct. 10-12 in Washington, where he is also expected to meet senior government officials. He was due to leave on Oct. 8. "It seem doubtful that he would be able to take stress for the long journey to the U.S. ...



via Health News Headlines - Yahoo News http://ift.tt/1voeny3

CORRECTION: Smartphone attachment eliminates doctor visits to diagnose ear infections

CellScope Oto enables at-home ear infection diagnoses If you can't imagine an otoscope smartphone attachment, it's probably because the only time you've ever seen one was at the doctor's office. It's here: an otoscope that enables you to view and capture images of the ear canal and eardrum on the smartphone's screen, and a corresponding app that lets you snap a picture and send it to your doctor for diagnosis.








via Health News Headlines - Yahoo News http://ift.tt/1qNwF5v